Business Standard

Mangalam Drugs and Organics reports standalone net loss of Rs 6.01 crore in the March 2019 quarter

Image

Capital Market

Sales decline 28.44% to Rs 48.09 crore

Net loss of Mangalam Drugs and Organics reported to Rs 6.01 crore in the quarter ended March 2019 as against net profit of Rs 3.06 crore during the previous quarter ended March 2018. Sales declined 28.44% to Rs 48.09 crore in the quarter ended March 2019 as against Rs 67.20 crore during the previous quarter ended March 2018.

For the full year,net loss reported to Rs 8.03 crore in the year ended March 2019 as against net profit of Rs 19.89 crore during the previous year ended March 2018. Sales declined 18.54% to Rs 227.58 crore in the year ended March 2019 as against Rs 279.38 crore during the previous year ended March 2018.

 
ParticularsQuarter EndedYear EndedMar. 2019Mar. 2018% Var.Mar. 2019Mar. 2018% Var.Sales48.0967.20 -28 227.58279.38 -19 OPM %0.5414.17 -4.2516.78 - PBDT-2.066.19 PL 1.3535.92 -96 PBT-3.723.61 PL -5.7429.35 PL NP-6.013.06 PL -8.0319.89 PL

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 10 2019 | 3:44 PM IST

Explore News